Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT02708680 |
Title | Randomized Phase 2 Study of Atezolizumab and Entinostat in Patients With aTN Breast Cancer With Phase 1b Lead In |
Recruitment | Completed |
Gender | female |
Phase | Phase Ib/II |
Variant Requirements | No |
Sponsors | Syndax Pharmaceuticals |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA |